Peter is a registered patent agent specializing in genetics and genomics, particularly the field of personalized medicine. Recent changes to patent laws and procedures (The Leahy-Smith America Invents Act, Mayo Collaborative Services v. Prometheus Laboratories, Inc., Association for Molecular Pathology v. Myriad Genetics) have created a complicated field for pursing patents in genetics, genomics, and personalized medicine. Guidances from the patent office have detailed paths to overcoming 101-based rejections to patentability based on the above two Supreme Court decisions. Peter uses his expertise in cutting-edge biotechnology to help clients secure patent rights for their inventions, and ensure that their patented claims serve the individual needs of each client’s business.
Peter’s research has focused on several fields. As a scientist working at Massachusetts General Hospital, he explored changes in brain structure in a mouse model of early-onset torsonial dystonia, a movement disorder with similar pathology to Parkinson’s. At Boston College, he explored novel mechanisms of how meiotic homologous recombination is regulated at retrotransposons in fission yeast. He has over ten years of experience in working with recombinant DNA, immunohistochemistry, whole-genome sequencing technology, and systems biology.
He is a teacher and a mentor for undergraduate students in both genetics and laboratory science. He has taught in both large seminar courses and small groups and is skilled in writing as a reviewer for scientific journals.